Who owns NOVABAY PHARMACEUTICALS INC?
- CUSIP Number: 66987p300
Tip: Access positions for across all investors
Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Novabay Pharmaceuticals stock
Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?
There are no current stakeholders of Novabay Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Novabay Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Mar 2024 | 149k | $16k |
| Tower Research Capital | Mar 2024 | 15k | $1.6k |
| Vanguard Group | Mar 2024 | 14k | $1.4k |
| Morgan Stanley | Mar 2024 | 158.00 | $17.000800 |
| Ronald Blue Trust | Jun 2024 | 37.00 | $3.999700 |
| Advisor Group Holdings | Mar 2024 | 37.00 | $3.999700 |